Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New ultrasound-guided procedure may offer better relief for stubborn trigger finger

NCT ID NCT05045157

Symptom relief Sponsor: Centre Hospitalier Departemental Vendee Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a minor ultrasound-guided procedure to cut the tight pulley in the finger, followed by a steroid injection, works better than a second steroid injection alone for people with trigger finger that didn't improve after the first shot. About 50 adults with persistent symptoms will be randomly assigned to one of the two treatments. The goal is to see which approach more effectively resolves pain and finger locking.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

May 2022

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient ≥ 18 years old, * Presence of a trigger finger (thumb or long fingers) to be treated * Quinnell score \>1 * Episode of trigger characterized on questioning or clinical examination * Failure of a first corticosteroid infiltration \> 3 months before inclusion * First infiltration within 15 months of inclusion * Thickening A1 pulley on ultrasound ≥ 0.5 mm * Patient who has the capacity to understand the protocol and has given consent to participate in the research, * Patient with social security coverage Exclusion Criteria: * Presence of several symptomatic fingers requiring treatment by ultrasound-guided section of the pulley * Patient who are pregnant, breastfeeding, or who have the potential to become pregnant without effective contraception at the time of inclusion * Known allergy to corticoid (Hydrocortancyl®) including its excipients ((benzyl alcohol, sodium carmellose, sodium chloride, polysorbate 80) * Known allergies to lidocaine * Ongoing anticoagulant treatments (AVK, New Oral Anti-Coagulants) * Local or general infection, or suspicion of infection * Live vaccines * Evolving viruses (hepatitis, herpes, varicella, shingles) * Severe or uncontrolled hypertension * Unbalanced diabetes * Underlying progressive cardiovascular disease * Hemodialysis patients * Prosthesis on the finger to be treated * Echographic tendon fissure * Inflammatory disease (rheumatoid arthritis, spondyloarthritis, connective tissue diseases, etc.) with tenosynovitis. * History of surgery on the fingers * Dupuytren's disease * Patient participating in another interventional clinical research protocol involving a drug or medical device * Patient under guardianship, curators or legal protection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Trigger finger are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

trigger thumb

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Trigger finger

Contacts and locations

Locations

  • CHD Vendée

    La Roche-sur-Yon, 85925, France

  • CHU Nantes

    Nantes, 44000, France

  • Hopital Henri Mondor

    Créteil, 94000, France

  • Hopital Lariboisière

    Paris, 75010, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.